Literature DB >> 16332487

Predictors of intensive care unit admission and related outcome for patients after pancreaticoduodenectomy.

David J Bentrem1, Jen J Yeh, Murray F Brennan, Ravi Kiran, Stephen M Pastores, Neil A Halpern, David P Jaques, Yuman Fong.   

Abstract

High-volume centers have low morbidity and mortality after pancreaticoduodenectomy (PD). Less is known about treatment pathways and their influence on intensive care unit (ICU) utilization. Patients who underwent PD at a tertiary cancer center during the five-year period between January 1998 and December 2003 were identified from a prospective database. Preoperative and intraoperative factors relating to ICU admission and outcome were analyzed. Five hundred ninety-one pancreaticoduodenectomies were performed during the study period. Of these, 536 patients had complete records for analysis. Of the 536 patients, 51 (10%) were admitted to the ICU after surgery. Admission to the ICU was associated with decreased overall survival (P < .0001). Of the preoperative predictors of ICU admission, serum creatinine, albumin, and increased body mass index (BMI) were associated with ICU admission (P = .02, .05, and .002, respectively). Age, blood glucose, diagnosis of diabetes mellitus, and chronic obstructive pulmonary disease were not predictive of ICU admission on univariate analysis. Of the intraoperative factors, longer operative time and estimated blood loss (EBL) correlated with ICU admission (P = .003 and .0001, respectively). On multivariate analysis, only preoperative BMI and intraoperative EBL were independent predictors of ICU admission (P = .03 and .003, respectively). Patients with a preoperative BMI greater than 30 had a substantially higher risk of ICU admission (relative risk 2.4). The majority of patients who undergo PD do not require admission to the ICU. Factors most associated with ICU admission after PD are increased preoperative BMI and intraoperative blood loss.

Entities:  

Mesh:

Year:  2005        PMID: 16332487     DOI: 10.1016/j.gassur.2005.09.010

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  44 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Predicting patient outcomes, futility, and resource utilization in the intensive care unit: the role of severity scoring systems and general outcome prediction models.

Authors:  Pedro A Mendez-Tellez; Todd Dorman
Journal:  Mayo Clin Proc       Date:  2005-02       Impact factor: 7.616

3.  Adiposity as compared with physical activity in predicting mortality among women.

Authors:  Frank B Hu; Walter C Willett; Tricia Li; Meir J Stampfer; Graham A Colditz; JoAnn E Manson
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

4.  The role of an intensive care unit in a community hospital. A ten-year review with observations on utilization past, present, and future.

Authors:  J B Nelson
Journal:  Arch Surg       Date:  1985-11

5.  Long-term survival is superior after resection for cancer in high-volume centers.

Authors:  Yuman Fong; Mithat Gonen; David Rubin; Mark Radzyner; Murray F Brennan
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

6.  Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.

Authors:  C J Yeo; J L Cameron; T A Sohn; K D Lillemoe; H A Pitt; M A Talamini; R H Hruban; S E Ord; P K Sauter; J Coleman; M L Zahurak; L B Grochow; R A Abrams
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

7.  Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients.

Authors:  S Benoist; Y Panis; V Pannegeon; A Alves; P Valleur
Journal:  Surgery       Date:  2001-04       Impact factor: 3.982

8.  Importance of hospital volume in the overall management of pancreatic cancer.

Authors:  J A Sosa; H M Bowman; T A Gordon; E B Bass; C J Yeo; K D Lillemoe; H A Pitt; J M Tielsch; J L Cameron
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

9.  The critically ill patient after hepatobiliary surgery.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

10.  Should pancreaticoduodenectomy be performed in octogenarians?

Authors:  T A Sohn; C J Yeo; J L Cameron; K D Lillemoe; M A Talamini; R H Hruban; P K Sauter; J Coleman; S E Ord; L B Grochow; R A Abrams; H A Pitt
Journal:  J Gastrointest Surg       Date:  1998 May-Jun       Impact factor: 3.267

View more
  19 in total

1.  Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection.

Authors:  Robert M Cannon; Ryan LeGrand; Ryaz B Chagpar; Syed A Ahmad; Rebecca McClaine; Hong Jin Kim; Christopher Rupp; Cliff S Cho; Adam Brinkman; Sharon Weber; Emily R Winslow; David A Kooby; Carrie K Chu; Charles A Staley; Ian Glenn; William G Hawkins; Alexander A Parikh; Nipun B Merchant; Kelly M McMasters; Robert C G Martin; Glenda G Callender; Charles R Scoggins
Journal:  HPB (Oxford)       Date:  2012-01-19       Impact factor: 3.647

2.  Peri-operative outcomes for pancreatoduodenectomy in India: a multi-centric study.

Authors:  Parul J Shukla; Savio G Barreto; Mms Bedi; N Bheerappa; Adarsh Chaudhary; Md Gandhi; M Jacob; S Jesvanth; Dg Kannan; Vinay K Kapoor; A Kumar; Kk Maudar; Hariharan Ramesh; Ra Sastry; Rajan Saxena; Ajit Sewkani; S Sharma; Shailesh V Shrikhande; A Singh; Rajneesh K Singh; R Surendran; Subodh Varshney; V Verma; V Vimalraj
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

3.  The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Thilo Welsch; Luca Degrate; Stefanie Zschäbitz; Stefan Hofer; Jens Werner; Jan Schmidt
Journal:  Langenbecks Arch Surg       Date:  2010-03-25       Impact factor: 3.445

4.  The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.

Authors:  Cristina R Ferrone; Barbara Haas; Laura Tang; Daniel G Coit; Yuman Fong; Murray F Brennan; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

Review 5.  Stents, glue, etc.: is anything proven to help prevent pancreatic leaks/fistulae?

Authors:  Richard D Schulick; Kiyoshi Yoshimura
Journal:  J Gastrointest Surg       Date:  2009-04-28       Impact factor: 3.452

Review 6.  Body mass index and outcomes from pancreatic resection: a review and meta-analysis.

Authors:  Andrew M Ramsey; Robert C Martin
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

Review 7.  Surgical intensive care unit - essential for good outcome in major abdominal surgery?

Authors:  Georg R Linke; Markus Mieth; Stefan Hofer; Birgit Trierweiler-Hauke; Jürgen Weitz; Eike Martin; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2011-03-03       Impact factor: 3.445

8.  Serum blood urea nitrogen and serum albumin on the first postoperative day predict pancreatic fistula and major complications after pancreaticoduodenectomy.

Authors:  Daniel M Relles; Nathan G Richards; Jordan P Bloom; Eugene P Kennedy; Patricia K Sauter; Benjamin E Leiby; Ernest L Rosato; Charles J Yeo; Adam C Berger
Journal:  J Gastrointest Surg       Date:  2012-12-06       Impact factor: 3.452

9.  Pancreatic adenocarcinoma: the actual 5-year survivors.

Authors:  Cristina R Ferrone; Murray F Brennan; Mithat Gonen; Daniel G Coit; Yuman Fong; Sun Chung; Laura Tang; David Klimstra; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

10.  Pyogenic liver abscess following pancreaticoduodenectomy: risk factors, treatment, and long-term outcome.

Authors:  Victor C Njoku; Thomas J Howard; Changyu Shen; Nicholas J Zyromski; C Max Schmidt; Henry A Pitt; Attila Nakeeb; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2014-02-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.